Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-02

Clinical Trial Update: Effect of the Consumption of an Enriched Surimi in Abdominal Visceral Adiposity [Phase 2]

View source ↗

Summary

Phase 2 clinical trial examining the effect of an enriched surimi on abdominal visceral adiposity in obesity; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • enriched surimi

Snippet

Sponsor: Technological Centre of Nutrition and Health, Spain | Conditions: Obesity, Abdominal | Phase 2 | Status: COMPLETED